Biological Engineering
1937–1979
Biological engineering focused on making living and semi-living matter engineerable through control of structure, interface, and process. Researchers transformed polymers and biomolecular toolchains into modular systems, standardizing enzyme purification and solid-phase peptide assembly. Investigators engineered surfaces, membranes, and flow fields as reusable platforms linking molecular function to system performance. These advances established generalizable tools for recombinant deoxyribonucleic acid technology, immobilized biocatalysis, and continuous bioprocess control.
Period 1937-1966: Researchers programmed polymer matrices and bioprocesses via controlled environments, gel tools, and microbial consortia[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. Standardized hydroponics, spore traps, immunoelectrophoresis, phenol DNA extraction, and digestion assays shaped later controlled agriculture and recombinant workflows[21][22][23][24][25]. Period 1967-1979: Immobilized enzymes[26][27][28][29][30][31], hydrodynamic propulsion[32][33][34], polymer hydrogels[35][36][37][38][39], microbial reactors[40][41][42], and vectors[43][44][45] established interface platforms. Landmark cloning[45], plaque-lift[46], blotting[47], packing-parameter[48], and chemostat[49] models shaped later biotechnology.
1980–1993
Researchers intensified bioprocesses by immobilizing enzymes and adopting continuous-flow reactors to boost productivity and stability. Biomaterials shifted toward function-by-design matrices tuned for controlled release, tissue integration, and bioactivity. Cross-kingdom gene delivery matured into standardized transformation workflows for mammalian cells, bacteria, and plants. Breakthrough reporter assays and vector systems accelerated gene discovery and catalyzed transgenic crop development.
Period 1980-1986: Immobilized biocatalytic continuous reactors[1][2][3][4][5], lignocellulose hydrolysis[6][7][8][9][10], hydrodynamic systems[2][11][12], enzymatic kinetics[6][13][7][8], and laser biomaterials[14][15][16][17][18] intensified bioprocesses. Reporter assays[19], binary vectors[20], extrusion vesicles[21], full-length cDNA[22], and UASB reactors[11] enabled modern genetic and environmental engineering. Period 1987-1993: Researchers mapped calcium-phosphate interlayers[23][24][25][26], optimized cross-kingdom gene delivery[27][28][29][30][31][32], degraded pollutants[33][34][35][36][37], and engineered stimuli-responsive polymers[38][39][40][41]. Standardized transfection and transformation protocols[42][43][44][45][46] established cloning benchmarks, while a tissue engineering blueprint[47] guided regenerative medicine.
1994–2010
Research united around integrating nanomaterials and soft matter with living systems through structure-property design and scalable processing. Soft lithography and microfluidic prototyping advanced alongside carbon nanotube devices and controlled delivery vehicles. Metabolic engineering reconstructed complex pathways in microbes for industrial terpenoid production. Later efforts shifted toward sustainability-driven energy and materials platforms via biomass fractionation, microalgal feedstocks, and microbial fuel cells.
Period 1994-2003: Carbon nanotubes, biomaterials, and polymers were synthesized via scalable routes to direct drug delivery, tissue growth, and biointegration[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. Landmark microfluidic, gene transfer, nanowire, metabolic, and reactor innovations shaped later synthetic biology and diagnostics[21][22][23][24]. Period 2004-2010: Biorefineries, microalgae, fuel cells, polymer photovoltaics, and nanoengineering integrated biomass, energy, wastewater, morphology, and synthesis using scalable frameworks[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44]. Standardized studies on algal biodiesel, microbial fuel cells, engineered yeast, and anaerobic digestion set enduring techno-economic baselines and platform pathways[28][35][45][46][47].
2011–2024
Research combined stretchable bioelectronics with dynamic hydrogels to develop skin-conformal sensors and advanced tissue-integrated platforms. Three-dimensional bioprinting matured through engineered bioinks, vascularization strategies, and functionalized extracellular matrix materials. Concurrently, precise genome editing tools and lipid nanoparticle delivery systems expanded therapeutic possibilities and clinical pipelines. Engineered human tissues also served as reliable translational testbeds for rapid pathogen screening and receptor-trap strategies.
Period 2011-2017: Stretchable bioelectronics, self-healing polymers, bioprinting hydrogel bioinks, nanocellulose, and organic optoelectronics yielded skin-conformal sensors and tissue constructs[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. Landmark bioprinting roadmaps, SaCas9 editors, nanoparticle design rules, alginate mechanics, and NanoLuc reporters drove manufacturable and translational bioengineering[9][21][22][23][24]. Period 2018-2024: Hydrated hydrogels, dynamic networks, and bioprinted nanocomposites achieved soft biointerfaces, self-healing wound care, and tissue-like sensing[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44]. Prime editing[45], tool syntheses[46], nanoparticle design rules[47], quality attributes[48], and engineered tissue screens[49] shaped translational nanomedicine and genomics.
Biomaterials and Bioprocess Engineering era
R. A. Terry[1] conducted research while affiliated with the Institute of Grassland Research[3] and Boehringer Ingelheim (South Korea)[4]. Through A TWO‐STAGE TECHNIQUE FOR THE <i>IN VITRO</i> DIGESTION OF FORAGE CROPS[6], they advanced the era's focus on engineering semi-living matter by establishing standardized methods for assessing biochemical digestibility and process control. J. M. A. Tilley[2] performed investigations at the Institute of Grassland Research[3] and the University of Oxford[5]. Their work on A TWO‐STAGE TECHNIQUE FOR THE <i>IN VITRO</i> DIGESTION OF FORAGE CROPS[6] contributed to the development of reusable analytical platforms linking molecular function and system performance in biological engineering.
Bioprocess Intensification and Surface Engineering era
Hiroto Okayama[7] conducted research at The University of Osaka[11] and Stanford University[12]. Through High-Efficiency Cloning of Full-Length cDNA[17], High-efficiency transformation of mammalian cells by plasmid DNA[15], and High efficiency transformation of Escherichia coli with plasmids[16], this researcher advanced cross-kingdom gene delivery by establishing standardized transformation workflows for cells. Bruce H. Howard[8] carried out scientific investigations at the National Cancer Institute[13] and the National Institutes of Health[14]. By publishing Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells[18], this investigator developed breakthrough reporter assays and vector systems that accelerated gene discovery. C Gorman[9] performed experimental work at the National Cancer Institute[13] and the National Institutes of Health[14]. The study Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells[18] contributed to this era by establishing foundational vector systems for gene expression in mammalian systems. Lindsey Moffat[10] contributed to the advancement of standardized transformation workflows. The work Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells[18] provided breakthrough reporter assays to accelerate gene discovery.
Nanomaterials and Integrated Biorefinery Engineering era
Charles M. Lieber[19] conducted research while affiliated with Harvard University[23][24]. Through Atomic structure and electronic properties of single-walled carbon nanotubes[27] and Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species[26], they advanced the integration of nanomaterials with biological systems via precise structure-property design. Yi Cui[20] performed investigations at Harvard University[23] and the California Institute of Technology[25]. Their work on Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species[26] contributed to sensitive and selective detection platforms that united soft matter and nanodevices with living systems. Hongkun Park[21] advanced the field while working at Harvard University[23] and Stanford University[12]. Through Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species[26], they helped pioneer nanostructured sensors for biological and chemical species detection. Qingqiao Wei[22] contributed to this research domain while based at Harvard University[23]. Their publication of Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species[26] furthered the scalable processing and prototyping of advanced nanomaterial devices for sensitive biological applications.
Soft Biointerfaces and Genomic Engineering era
David Mooney[28], working at Harvard University[23] and Harvard University Press[24], contributed to the development of functionalized extracellular matrix materials and tissue-integrated platforms. Through the publication of Alginate: Properties and biomedical applications[32], this work detailed the versatile structural and biological capabilities of alginate hydrogels for soft biointerfaces. Kuen Yong Lee[29], conducting research at Hanyang University[30] and Bioengineering Center[31], further advanced dynamic hydrogel systems within the field. This was achieved via Alginate: Properties and biomedical applications[32], which elucidated how crosslinking and polymer properties enable robust, customizable scaffolds for tissue engineering.
Biomaterials and Bioprocess Engineering
Bioprocess Intensification and Surface Engineering
Nanomaterials and Integrated Biorefinery Engineering
Soft Biointerfaces and Genomic Engineering
R. A. Terry and J. M. A. Tilley
Hiroto Okayama and 3 others
Charles M. Lieber and 3 others
20
Yi CuiDavid Mooney and Kuen Yong Lee